This research was supported by a BBSRC PhD studentship award for CS Increasing skeletal muscle carnitine availability alters muscle metabolism during steady-state exercise in healthy humans. We investigated whether elevating muscle carnitine, and thereby the acetyl-group buffering capacity, altered the metabolic and physiological adaptations to 24 weeks of high-intensity interval training (HIIT) at 100% maximal exercise capacity (Watt max ). Twenty-one healthy male volunteers (age 23±2 years; BMI 24.2±1.1 kg/m 2 ) performed 2 × 3 minute bouts of cycling exercise at 100% Watt max , separated by 5 minutes of rest. Fourteen volunteers repeated this protocol following 24 weeks of HIIT and twice-daily consumption of 80 g carbohydrate (CON) or 3 g l-carnitine+carbohydrate (CARN). Before HIIT, muscle phosphocreatine (PCr) degradation (P<.0001), glycogenolysis (P<.0005), PDC activation (P<.05), and acetylcarnitine (P<.005) were 2.3-, 2.1-, 1.5-, and 1.5-fold greater, respectively, in exercise bout two compared to bout 1, while lactate accumulation tended (P<.07) to be 1.5-fold greater. Following HIIT, muscle free carnitine was 30% greater in CARN vs CON at rest and remained 40% elevated prior to the start of bout 2 (P<.05). Following bout 2, free carnitine content, PCr degradation, glycogenolysis, lactate accumulation, and PDC activation were all similar between CON and CARN, albeit markedly lower than before HIIT. VO 2max , Watt max , and work output were similarly increased in CON and CARN, by 9, 15, and 23% (P<.001). In summary, increased reliance on non-mitochondrial ATP resynthesis during a second bout of intense exercise is accompanied by increased carnitine acetylation. Augmenting muscle carnitine during 24 weeks of HIIT did not alter this, nor did it enhance muscle metabolic adaptations or performance gains beyond those with HIIT alone.
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| INTRODUCTION
The reversible esterification of skeletal muscle free carnitine with acetyl-CoA, by the mitochondrial enzyme carnitine acetyltransferase (CAT), maintains a viable pool of free coenzyme A and thereby facilitates pyruvate dehydrogenase complex (PDC) and TCA cycle fluxes under conditions of elevated ATP demand. 1, 2 This is evidenced by the linear relationship that exists between acetyl-CoA and acetylcarnitine accumulation across submaximal exercise intensities, 2, 3 as well as the finding that increasing skeletal muscle free carnitine availability in healthy humans resulted in a greater acetylcarnitine accumulation and PDC activation during exercise at 80% maximal aerobic capacity (VO 2max ), which was concomitant with a lower rate of phosphocreatine (PCr) degradation and a diversion of glycogenolysis away from
lactate accumulation. 4 However, during very intense exercise there is a plateau in muscle acetyl-group concentration that is associated with a greatly accelerated rate of lactate production. 5, 6 This increasing lactate formation and associated acidosis is often cited as a key component in the reduction in oxidative phosphorylation and development of fatigue during very intense exercise. 7 Under these conditions, it is unclear whether free carnitine availability is limiting to PDC flux and mitochondrial ATP resynthesis, or simply that TCA cycle flux and PDC flux are maximal and well matched. In support of the latter, it was previously demonstrated that during 5 minutes of leg extension exercise at 100% maximal workload (Watt max ), in vitro determination of PDC activation accounted for 90% of the estimated TCA cycle flux from leg O 2 uptake. 8 Moreover, using the same model Bangsbo et al. 9 reported that mitochondrial ATP delivery was enhanced in a second 3-minute bout of single-leg extension at 100% Watt max , when free carnitine availability would presumably have been reduced. 10 However, the limitations to mitochondrial ATP delivery during single-leg exercise are not entirely analogous with two-legged cycling 11, 12 and skeletal muscle carnitine metabolism was not determined in these studies. Exercise training robustly enhances the capacity for mitochondrial ATP resynthesis and is paralleled by reciprocal reductions in the reliance on PCr degradation and glycolytic ATP delivery. 13 These metabolic adaptations reflect a better matching of glycolysis, PDC, and TCA cycle fluxes and underpin the functional improvements observed in power output and endurance performance following classical endurance exercise . 14 Low-volume, high-intensity interval exercise (HIIT) is much promoted as a time-efficient strategy to stimulate metabolic and functional adaptations comparable to continuous endurance-type exercise 15 and is well tolerated when practical workloads (i.e, ~100% VO 2max ) are employed. 16 This type of exercise paradigm markedly increases glycolytic and mitochondrial ATP demand, but the acetylgroup buffering role of carnitine under these conditions has not been investigated. If carnitine availability is indeed limiting to PDC flux during intense, repeated-bout exercise, it is plausible that increasing skeletal muscle carnitine availability as in ref. 4 during a prolonged period of HIIT could influence the adaptations to this type of training. This study was conducted to gain further insight into the role of skeletal muscle acetyl-group buffering, PDC flux, and mitochondrial ATP production during high-intensity interval exercise. It was hypothesized that skeletal muscle free carnitine would decline progressively across two consecutive bouts of fixed-workload cycling exercise at Watt max . It was subsequently hypothesized that increasing muscle free carnitine during a 24-week period of HIIT would lower the reliance on non-mitochondrial ATP production during a second bout of intense exercise and consequently alter the training-induced adaptations in exercise capacity (VO 2max , Watt max ) and performance (work output). 
| Protocol

| Baseline testing
The overall study protocol is depicted in Figure 1A . subsequently cycled for 3 minutes at their predetermined Watt max workload and, upon cessation of exercise, a second biopsy was immediately obtained from the same leg as the first. Volunteers then rested for 5 minutes before completing a second 3-minute bout of exercise at the same absolute workload, with further biopsies obtained from the contralateral leg immediately before and after the second bout ( Figure 1B ). Following the initial baseline experimental visit, fourteen volunteers were randomized to receive either l-carnitine (n=7) or placebo (n=7) supplementation during a 24-week period of supervised HIIT, with the absolute training workload adjusted to reflect any changes in Watt max which, along with VO 2max , was reassessed after 4, 8, 12, 18, and 24 weeks. The main experimental study visit was then repeated at 24 weeks, and an additional resting muscle biopsy was obtained at 12 weeks.
| High-intensity interval training
Volunteers trained three times per week (normally Monday, Wednesday, and Friday) and were required to complete >85% of all training sessions over 24 weeks for inclusion in the final data set. All training sessions involved a 3-minute warm-up at 25% Watt max followed by 3 × 3 minute exercise bouts at Watt max and a fourth bout to exhaustion, each separated by 5-minute passive recovery periods. During the fourth bout of each training session, volunteers received standardized verbal encouragement to exercise as long as they could (typically <5 minutes). The absolute training workload was adjusted, in line with the reassessment of Watt max every four weeks ( Figure 1A ), to maintain a constant relative intensity of Watt max . Additionally, when volunteers were able to exercise for 6 minutes in the final bout during more than two consecutive training sessions, the workload was increased by a further 1% for the subsequent training session. This approach maximized total work output, while restricting exercise duration to 15 minutes, in every training session.
| Supplementation
Volunteers were assigned to receive twice-daily beverages of either 80 g carbohydrate (Maldex 180; SYRAL, Aalst, Belgium; CON) or 80 g carbohydrate plus 2.25 g l-carnitine tartrate (1.5 g l-carnitine; Nutramet, Nottingham, UK; CARN) in a randomized, double-blinded fashion. The quantities of l-carnitine and carbohydrate provided were identical to those used in a prior study. 4 Drinks were made up in 500 mL cold water from sachets of powder and were matched for flavor, appearance, and carbohydrate type. Volunteers were instructed to consume one beverage first thing in the morning, and the second beverage 4 hours later to maximize the time period over which plasma carnitine and serum insulin concentrations were simultaneously elevated.
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| Sampling and analysis
Muscle biopsies were rapidly frozen (~10 seconds) in liquid nitrogen-cooled isopentane and a ~50 mg (wet weight; [ww]) portion was freeze-dried for the determination of free, acetyl, and total carnitine, 21 as well as ATP, PCr, lactate, and glycogen, corrected (excluding lactate) for muscle total creatine.
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A second portion (~15 mg ww) was used for the determination of PDC activation status. 23 Total carnitine was also determined in the 12-week muscle biopsy and in plasma samples. In non-occluded muscle, this equation ignores lactate efflux and intermediary metabolite concentrations, but still provides a relative index reflective of the overall matching of oxidative ATP production to total ATP demand. Glycogenolysis was calculated as Δ [glycogen] . To evaluate the influence of the repeated-bout exercise paradigm on skeletal muscle metabolism, baseline metabolite concentrations and delta values for the pooled subjects (n=21) were compared using two-way ANOVA (acute exercise × bout) or paired t test, respectively (as in Figure 2 ). Two-way ANOVA was also employed to evaluate the effects of carnitine supplementation and HIIT on exercise capacity and performance (group × time; as in Figure 3 ) as well as on skeletal muscle metabolism following HIIT (group × bout; as in Figure 4 ) or (group × time; as in Table S1 ). All data are presented as mean±SE, with absolute metabolite concentrations expressed in mmol/kg dry weight (dw) and significance level set at P<.05. Muscle free carnitine concentration declined by 28% (P=.03) during bout 1 and remained unchanged during recovery, before declining a further 39% (P=.008) during bout 2 ( Figure 2A ). Acetylcarnitine concentrations mirrored the decline in free carnitine, increasing by 2.3-fold and 1.7-fold during bout 1 and bout 2, respectively (both P=.02; Figure 2A ), while absolute acetylcarnitine accumulation (Δ[acetylcarnitine]) was similar between bouts 1 and 2 (4.1±0.9 and 4.2±0.9 mmol/kg dw, respectively). PDCa increased 2.1-fold (P=.009) during bout 1 before returning to basal values prior to the start of bout 2. During bout 2, PDCa increased 3.3-fold (P<.001), to a greater extent than during bout 1 (interaction effect P=.03; Figure 2B ). tending to be 1.5-fold greater during bout 2 than bout 1 (P=.07; Figure 2C , dotted bars). The total calculated ATP delivery from non-mitochondrial routes was 1.7-fold greater during bout 2 versus bout 1 (159.4±12.0 vs 93.3±19.5 mmol ATP/kg dw; P=.007; Figure 2C , summed bars). Resting muscle glycogen concentration was 396±18 mmol/kg dw and declined by 15% and 32% during bout 1 and bout 2, respectively (both P<.001), such that Δ[glycogen] was 2.1-fold greater during bout 2 than bout 1 (P<.001; Figure 2D ).
| Calculations and statistical analyses
| Postsupplementation
Following randomization, CON and CARN groups were well matched for baseline exercise capacity ( Figure 3A-C) and skeletal muscle metabolism during repeated-bout exercise (Table S1 ).
| Exercise capacity and work performance
Twenty-four weeks of HIIT increased VO 2max by ~9% ( Figure 3A) , Watt max by ~15% ( Figure 3B ), and work output during training by ~23% ( Figure 3C ) in CON and CARN (all P<.001), with no differences between groups. These adaptations occurred primarily between 0 and 12 weeks, with no further improvements observed between 12 and 24 weeks ( Figure 3A-C) . Relative changes were not influenced by normalizing values to body weight.
| Postsupplementation skeletal muscle carnitine metabolism and PDCa
Skeletal muscle total carnitine in the CON group decreased from baseline to 12 weeks (17.8±1.0 vs 15.7±1.2; P=.04) but was no different from baseline by 24 weeks (16.9±1.0; P=.17 vs baseline). In contrast, total carnitine in the CARN group was unchanged from baseline at 12 weeks (19.4±129 vs 19.5±1.9; P=.9) but tended to increase at 24 weeks (20.9±1.8; P=.06 vs baseline), such that the absolute change from baseline was significantly greater in CARN than CON (1.5±0.7 vs −0.9±0.6 mmol/kg dw; P=.04). This resulted in a 30% greater resting free carnitine availability in CARN versus CON (P=.03) and, following an initial exercise bout, free carnitine remained 28% greater in CARN vs CON (P=.03; Figure 4A ). However, following the second exercise bout, free carnitine values were similar between groups ( Figure 4A ). Postexercise PDCa was no different between CON and CARN for either exercise bout ( Figure 4B ).
| Postsupplementation nonmitochondrial ATP delivery and glycogenolysis
ATP, PCr degradation, and lactate accumulation following HIIT were all similar between CON-and CARN-treated groups in both exercise bouts ( Figure 4C ). There was a main effect of HIIT for reducing Δ[PCr] and Δ[lactate] across both groups in bout 1 (P=.03) and bout 2 (P=.006). Resting muscle glycogen increased 1.5-and 1.4-fold in CON (P=.009) and CARN (P=.02), respectively, following HIIT but remained similar between groups. There were no differences in Δ[glycogen] between CON and CARN during bout 1 or bout 2 ( Figure 4D ), although Δ[glycogen] in bout 2 was lower for both groups following HIIT (main effect of HIIT; P=.007).
| DISCUSSION
The principle finding of the present study was that increasing skeletal muscle free carnitine content and the capacity to buffer excess acetyl-groups during repeated 3-min bouts of high-intensity exercise at 100% Watt max did not further influence skeletal muscle metabolism during this exercise paradigm, nor did it improve training-induced changes in muscle metabolism, VO 2max , Watt max , or work output over 24 weeks of high-intensity interval training (HIIT). This would suggest that either acetylcarnitine formation or PDC flux is not limiting to mitochondrial ATP delivery during repeated bouts of exercise of this duration and intensity, or that the adaptations to HIIT outweighed any benefit of increasing free carnitine availability. Indeed, a novel finding of the present study was that during a repeated bout of intense cycling exercise at Watt max , where free carnitine availability was reduced, the reliance on phosphocreatine degradation increased, which is indicative of a declining contribution from mitochondrial ATP delivery. However, following 24 weeks of HIIT nonmitochondrial ATP production and acetylcarnitine accumulation during a second bout of exercise were blunted to such an extent that they were lower than the pretraining first bout. Taken together, these data suggest that 24 weeks of HIIT per se results in a better matching of PDC and TCA cycle flux during repeated bouts of exercise, lowering the dependence on mitochondrial acetyl-group buffering.
In contrast to previous reports that reliance on nonmitochondrial ATP delivery is lessened over repeated bouts of intense exercise, 9,10 here we observed a twofold greater PCr degradation during the second exercise bout relative to the first. Resynthesis of PCr, via the mitochondrial creatine kinase shuttle, relies on mitochondrial ATP provision, 25 and thus, the extent of PCr degradation during exercise can be considered a sensitive marker of mitochondrial ATP delivery. Indeed, total non-mitochondrial ATP production, a reciprocal index of oxidative ATP delivery, was 71% greater during the second exercise bout. Assuming a negligible contribution from fat oxidation at this intensity 26 and taken together with the continued rise in muscle lactate concentrations and the doubling of glycogenolysis, these data strongly contend that mitochondrial ATP provision was compromised during the second bout relative to the first. The discrepancy between this finding and data from previous studies could relate to methodological differences. For example, Bangsbo et al. 9 assessed rates of PCr degradation during two bouts of single-leg knee extension, which allows a greater blood flow per unit muscle mass and likely imposes more modest restrictions on mitochondrial ATP delivery. 12 Alternatively, the increased reliance on substrate-level phosphorylation and glycolysis in a second exercise bout could potentially reflect an increased overall ATP demand, due to the purported reduction in skeletal muscle efficiency that may develop during high-intensity exercise. 27 Measurement of VO 2 kinetics in the present study may have shed more light on this. Ultimately, the observed increase in non-mitochondrial ATP delivery during the second exercise bout reflects a greater mismatch between oxidative ATP delivery and total ATP demand. Therefore, we postulated that despite similar or greater PDC activation, the continued decline of free carnitine availability during a second exercise bout may restrict acetyl-group delivery to the TCA cycle by impairing PDC flux, 4 which thus provides a rationale for attempting to manipulate muscle carnitine content during chronic HIIT. Using the same l-carnitine supplementation strategy as that employed previously in our lab, 4 here we were able to increase resting skeletal muscle free carnitine availability following a period of HIIT. Importantly, and in line with previous findings of Wall et al., 4 this postsupplementation elevation of free carnitine persisted throughout, and during recovery from, the first exercise bout at 100% Watt max . The latter was hypothesized to prevent the apparent decline in mitochondrial ATP production during a second exercise bout, as observed prior to supplementation, by facilitating a greater flux through the PDC. However, postsupplementation neither PDC activation nor carnitine acetylation was appreciably different between CON and CARN following bout 2, which would suggest that PDC flux during the second bout was comparable between groups. Thus, it would appear that the increased availability of free carnitine in CARN did not translate into an enhancement of mitochondrial acetyl-group delivery or any further sparing of PCr degradation or lactate accumulation compared to CON. This is somewhat surprising, considering the robust physiological and gene network adaptations previously reported in carbohydrate and lipid metabolism following carnitine supplementation. 4, 28 The previously reported adaptations were observed in 7 participants, so it is unlikely that differences in the present study were masked by insufficient power. It is possible that the 3-minute exercise bouts employed in the current study were of insufficient duration to allow the plateau in acetyl-group accumulation typically observed within 10 minutes of exercise at 75%-90% VO 2max , 29, 30 such that the maximal capacity of carnitine to buffer mitochondrial acetyl-group accumulation becomes less critical. Indeed, carnitine acetylation during bout 2, following HIIT, in the current study reached only ~35% of the free + acetylcarnitine pool. This value is approximately half that observed following 20 minutes of exercise at 80% VO 2max , whereupon increasing skeletal muscle carnitine availability did indeed influence anaerobic energy production. 4 In this respect, the lower intensity and greater duration of the exercise protocol employed by Wall et al. 4 likely permitted a greater contribution of lipids to acetyl-group delivery than in the current study, 31 which may augment the dependence of mitochondrial ATP production on free carnitine availability. Regardless of free carnitine availability, HIIT reduced muscle lactate accumulation across both exercise bouts. We did not determine muscle lactate efflux in the current study, which would likely have been greater during the second exercise bout and further enhanced following HIIT. 32 Nevertheless, the parallel reductions in both glycogen and PCr utilization following HIIT are consistent with a lower lactate production, likely as a result of reduced glycolytic flux and enhanced pyruvate oxidation. Despite these robust metabolic adaptations, reliance on non-mitochondrial ATP delivery following HIIT was still markedly greater in a second exercise bout relative to the first. Increasing free carnitine availability prior to the start of the second bout did not alter this, suggesting that factors other than the mitochondrial acetyl-group buffering capacity are limiting oxidative ATP delivery under these conditions. In view of these data, it seems unlikely that metabolic flux was appreciably altered in CARN during training sessions, where four successive exercise bouts were performed at Watt max , particularly as work output was equivalent between groups throughout the 24-week HIIT period, and it is thus perhaps unsurprising that the gains in VO 2max and Watt max were comparable. Limited data exist on the plasticity of the muscle carnitine stores in response to exercise training. Here, we found 12 weeks of HIIT to be associated with a transient 12% decline in skeletal muscle total carnitine content (in CON), before partial restoration after 24 weeks continued training. Importantly, and consistent with one previous report on the impact of l-carnitine supplementation during training, 33 the carnitine loading strategy used here was able to avert the observed decline in muscle carnitine content. The reason for the initial decline in muscle carnitine in CON is unclear, but given the prospective influence of habitual diet on the transcriptional regulation of tissue carnitine content, [34] [35] [36] could be an adaptation to the 160 g/d carbohydrate load, which we have previously shown to influence transcription factor (e.g, PPARα) expression in skeletal muscle differentially to carbohydrate plus l-carnitine feeding. 28 Alternatively, the decline in muscle carnitine content could reflect an adaptation to the highly glycolytic nature of the training paradigm during the initial 8-12 weeks of the intervention when the gains in work output and VO 2max (and presumably metabolic adaptations) were greatest. Indeed, the 10% improvement in VO 2max we report here is consistent with the ranges (3%-15%) reported by several recent meta-analyses of HIIT studies typically lasting <8 weeks. [37] [38] [39] Moreover, previous studies have demonstrated a similar reduction in skeletal muscle non-mitochondrial ATP production during submaximal exercise, as well as increased resting muscle glycogen content (albeit to a lesser degree than the present study of 17% vs 44%) following 2-6 weeks of HIIT. 15, 16 Thus, the temporal nature of the adaptations observed here raises the question as to whether the widely reported health benefits of short-term HIIT 38, 40 can continue to improve beyond 12 weeks.
In conclusion, these data demonstrate that daily lcarnitine and carbohydrate feeding can be used to manipulate skeletal muscle free carnitine content during a sustained period of HIIT. However, elevating muscle free carnitine availability during HIIT does not appear to influence the training-induced increase in mitochondrial ATP provision across repeated bouts of high-intensity cycling exercise, suggesting that the skeletal muscle adaptations to HIIT are not restricted by free carnitine availability or the mitochondrial acetyl-group buffering capacity. As a result, the whole-body gains in exercise performance and capacity following HIIT were not augmented by the manipulation of muscle carnitine content.
| PERSPECTIVES
Recent concepts on the acetyl-group buffering role of carnitine in human health and metabolic disease lack longitudinal support. 41 Here, we increased free carnitine availability during a 24-week period of HIIT and show that the skeletal muscle acetyl-group buffering capacity is unlikely limiting to the metabolic and physiological adaptations to this type of training paradigm. Nevertheless, augmenting skeletal muscle carnitine content can demonstrably alter steady-state exercise metabolism, body adiposity, and the expression of related gene networks. 4, 28 These observations may still be relevant to training paradigms that employ steady-state exercise intensities lower than 100% Watt max and are worthy of further study, particularly in conditions where lipid or carbohydrate metabolism may be perturbed. Indeed, despite experimental reports classifying the carnitine-derived metabolite trimethylamine N-oxide as proatherogenic, 42 prolonged carnitine supplementation would appear to have a safe and beneficial role in cardiovascular health. 43 
